🔗 Share this article

The prestigious award in medical science was awarded for transformative discoveries that clarify how the body's defense network targets dangerous infections while protecting the body's own cells.

Three esteemed scientists—Japan's Prof. Sakaguchi and American experts Mary Brunkow and Fred Ramsdell—received this accolade.

The work identified unique "sentinels" within the immune system that remove malfunctioning defense cells capable of attacking the body.

These discoveries are now enabling innovative treatments for immune disorders and cancer.

These winners will divide a prize fund valued at 11 million Swedish kronor.

Crucial Findings

"The research has been decisive for understanding how the immune system operates and why we don't all suffer from serious self-attack conditions," stated the chair of the award panel.

This trio's studies explain a fundamental mystery: How does the defense system protect us from countless invaders while leaving our healthy cells unharmed?

Our body's protection system uses white blood cells that search for indicators of infection, including viruses and bacteria it has never encountered.

These defenders employ detectors—called recognition units—that are generated randomly in countless combinations.

That gives the defense network the ability to combat a wide array of invaders, but the randomness of the process inevitably creates immune cells that can target the body.

Security Guards of the Immune System

Researchers earlier understood that a portion of these harmful defense cells were eliminated in the immune organ—the site where white blood cells develop.

The latest Nobel Prize honors the discovery of regulatory T-cells—described as the immune system's "peacekeepers"—which travel through the body to neutralize any immune cells that attack the body's own tissues.

We know that this process fails in autoimmune diseases such as type-1 diabetes, MS, and RA.

The Nobel panel stated, "These findings have laid the foundation for a new field of investigation and spurred the development of new therapies, for example for tumors and immune disorders."

Regarding cancer, T-regs prevent the system from attacking the tumor, so studies are aimed at lowering their quantity.

For autoimmune diseases, experiments are testing boosting T-reg cells so the organism is no longer under attack. A comparable approach could also be useful in reducing the risks of organ transplant rejection.

Innovative Experiments

Prof Shimon Sakaguchi, of a Japanese institution, conducted experiments on rodents that had their thymus removed, causing self-attack conditions.

He demonstrated that introducing defense cells from healthy animals could prevent the illness—implying there was a system for blocking immune cells from attacking the host.

Dr. Brunkow, affiliated with the a research center in Seattle, and Fred Ramsdell, now at a biotech firm in a California city, were studying an genetic immune disorder in rodents and people that resulted in the identification of a gene vital for how T-regs operate.

"Their pioneering work has uncovered how the body's defenses is controlled by regulatory T cells, stopping it from mistakenly attacking the body's own tissues," commented a prominent biological science expert.

"The research is a remarkable example of how fundamental physiological study can have broad consequences for public health."